ORNA THERAPEUTICS
Orna Therapeutics is a biotechnology company dedicated to designing and delivering a new class of fully engineered circular RNA (oRNA) therapeutics with the potential to change the way we treat disease. The company's proprietary platform combines novel technology to create oRNAs that drive protein expression with validated and unique delivery solutions. Orna Therapeutics was established in 2019 by Alex Wesselhoeft and Raffaella Squilloni in Cambridge, Massachusetts.
ORNA THERAPEUTICS
Industry:
Biotechnology Medical Pharmaceutical Therapeutics
Founded:
2019-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.ornatx.com
Total Employee:
51+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
321 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Font Awesome Global Site Tag Sitelinks Search Box
Similar Organizations
Abata Therapeutics
Abata Therapeutics is a biotech company.
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Bio-Detection K9
Bio-Detection K9 is a biotech company specialized in the canine detection of bacteria and viruses particular of covid-19.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Starton Therapeutics
Starton Therapeutics is a biotechnology company that focuses on transforming standard of care in therapeutics.
Kymera Therapeutics
Kymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation.
Remix Therapeutics
Remix Therapeutics is a biotechnology company.
TheraCea Pharma
TheraCea Pharma is a biotechnology company that develops precision medicine to help people with neurological disorders.
Current Employees Featured
Founder
Investors List
MPM Capital
MPM Capital investment in Series B - Orna Therapeutics
BioImpact
BioImpact investment in Series B - Orna Therapeutics
Merck
Merck investment in Series B - Orna Therapeutics
MPM Capital
MPM Capital investment in Series A - Orna Therapeutics
The Pags Group
The Pags Group investment in Series A - Orna Therapeutics
Astellas Venture Management
Astellas Venture Management investment in Series A - Orna Therapeutics
F2 Ventures
F2 Ventures investment in Series A - Orna Therapeutics
Taiho Ventures
Taiho Ventures investment in Series A - Orna Therapeutics
Bristol Myers Squibb
Bristol Myers Squibb investment in Series A - Orna Therapeutics
Novartis Institutes for Biomedical Research
Novartis Institutes for Biomedical Research investment in Series A - Orna Therapeutics
Key Employee Changes
Date | New article |
---|---|
2021-12-16 | Orna Therapeutics Expands Leadership Team with Key Executive Hires |
Official Site Inspections
http://www.ornatx.com Semrush global rank: 5.07 M Semrush visits lastest month: 1.62 K
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Orna Therapeutics"
About Us - Orna Therapeutics
Our team has the experience to take our comprehensive oRNA ® and LNP platform โฆSee details»
Orna Therapeutics - Crunchbase Company Profile
Contact Email [email protected] Orna Therapeutics is a biotechnology company dedicated to designing and delivering a new class of fully engineered circular โฆSee details»
Orna Therapeutics - LinkedIn
Orna Therapeutics is a biotechnology company reshaping RNA therapeutics. We are developing the leading circular RNA technology platform (oRNA®) and unprecedented lipid nanoparticle (LNP) delivery ...See details»
Orna Therapeutics - Overview, News & Similar companies
May 22, 2024 Orna Therapeutics contact info: Phone number: (617) 977-6357 Website: โฆSee details»
Careers - Orna Therapeutics
Please note that Orna partners with select organizations to recruit talent. To avoid scams targeting our candidates, correspondence from our recruiting team will only come from [email protected] or other @ornatx.com addresses. Our โฆSee details»
Orna Therapeutics CEO and key executive team - Craft.co
Orna Therapeutics's Chief Executive Officer is Thomas Barnes. Other executives include John โฆSee details»
Orna Therapeutics - VentureRadar
"Orna Therapeutics is an MIT spin-off developing fully engineered circular RNA (oRNA) โฆSee details»
Merck and Orna Therapeutics Collaborate to Advance Ornaโs Next ...
Aug 16, 2022 Contacts. Merck Media: Melissa Moody (215) 407-3536 Justine Moore (908) โฆSee details»
Merck and Orna Therapeutics Collaborate to Advance Ornaโs Next ...
Aug 16, 2022 To learn more visit: www.ornatx.com and follow Orna Therapeutics on Twitter โฆSee details»
Orna Therapeutics Announces Strategic Acquisition of โฆ
May 23, 2024 To learn more, visit www.ornatx.com and follow Orna Therapeutics on X and LinkedIn. About ReNAgade Therapeutics ReNAgade exists to unlock the potential for RNA medicines to treat disease anywhere ...See details»
Orna Therapeutics Launches with over $100M Raised to Develop a โฆ
Www.ornatx.com and follow Orna Therapeutics on Twitter and LinkedIn. About MPM Capital โฆSee details»
Orna Therapeutics Launches with over $100M Raised to Develop a โฆ
CAMBRIDGE, Mass., Feb. 24, 2021 /PRNewswire/ -- Orna Therapeutics, a biotechnology โฆSee details»
Orna - Company Profile - Tracxn
Aug 17, 2021 Orna ranks 2nd among 43 active competitors. 16 of its competitors are funded โฆSee details»
Orna Therapeutics: Culture | LinkedIn
Website: www.ornatx.com. Orna Therapeutics | 20,477 followers on LinkedIn. Ahead of the โฆSee details»
Orna Therapeutics Announces Strategic Acquisition of ReNAgade ...
May 23, 2024 Orna Therapeutics, a biotechnology company dedicated to designing and โฆSee details»
Our Approach & Strategy - Orna Therapeutics
Each segment of the oRNA ® sequence is designed for a specific effect: driving circularization, โฆSee details»
Orna Therapeutics Unveils Progress of Circular RNA Platform and ...
May 18, 2023 /PRNewswire/ -- Orna Therapeutics, a biotechnology company pioneering a โฆSee details»
Our Pipeline - Orna Therapeutics
Ornaโs in vivo CAR platform (panCARโข) combines oRNA ® technology with our proprietary โฆSee details»
News & Media - Orna Therapeutics
Latest news will be published here.See details»